Cho Yong-ho

HLB Life Science President · 1 stock

Value held (filed)$6.1M1 direct holdings

30-day netNo change

Holdings

Value Stake Latest filing

HLB Life Sciencedirect 2.70% · avg $6.66 −72%2.70%$6.1M

2 indirect-only holdings

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

HLB Pharmaceuticalindirect 0.38%0.38%$934K

HLB Life Science 2.70% → HLB Pharmaceutical 14.05%0.38%

HLB innoVationindirect 0.24%0.24%$910K

HLB Life Science 2.70% → HLB Pharmaceutical 14.05% → HLB innoVation 7.84%0.03%
HLB Life Science 2.70% → HLB innoVation 7.89%0.21%

Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.